Numerous parallels can be drawn between the EU AI Act and product safety legislation - including risk classification for product liability, conformity assessments, CE marking and post-market surveillance – all of which are mirrored in the Act.

But are organisations that are well-versed in placing safety-critical products on the market, better prepared to comply with the product safety aspects of the EU AI Act than others?

In the second episode of our mini-series focusing on this significant regulatory change, host Anneke Pol is joined by Charlie Hawes and Alex Denoon to:

• Explore some of these parallels in more detail; and
• Share some takeaways from medical device legislation for those looking to comply with the product safety features of the Act – particularly in the context of “high risk” AI systems.

Please also take a look at our recent article series on the EU AI Act in which we address these subjects further – high risk AI, provider and deployer roles, product safety requirements, AI governance, and IP and employment issues under the Act.

Also, are you joining us for our Tech Summit 2024 taking place on 16 October 2024 in London?

Send us a Text Message.

Thanks for listening!
If you have any feedback, questions or comments, please email us at theroadmap@bristows.com

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on X and LinkedIn using #TheRoadmapPod

Note: All information was correct at the time of recording.